HL
Harding Loevner’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,452,716
| Closed | -$111M | – | 73 |
|
|
2023
Q4 | $111M | Sell |
1,452,716
-23,843
| -2% | -$1.82M | 0.62% | 54 |
|
|
2023
Q3 | $102M | Sell |
1,476,559
-217,390
| -13% | -$15.1M | 0.68% | 52 |
|
|
2023
Q2 | $160M | Sell |
1,693,949
-332,877
| -16% | -$31.4M | 0.93% | 43 |
|
|
2023
Q1 | $168M | Sell |
2,026,826
-15,731
| -0.8% | -$1.3M | 0.95% | 43 |
|
|
2022
Q4 | $152M | Buy |
2,042,557
+216,804
| +12% | +$16.2M | 0.88% | 44 |
|
|
2022
Q3 | $151M | Sell |
1,825,753
-98,129
| -5% | -$8.11M | 0.99% | 37 |
|
|
2022
Q2 | $183M | Sell |
1,923,882
-51,652
| -3% | -$4.91M | 1.13% | 29 |
|
|
2022
Q1 | $189M | Sell |
1,975,534
-131,560
| -6% | -$12.6M | 1.04% | 36 |
|
|
2021
Q4 | $273M | Sell |
2,107,094
-43,146
| -2% | -$5.59M | 1.05% | 38 |
|
|
2021
Q3 | $243M | Sell |
2,150,240
-78,314
| -4% | -$8.87M | 0.97% | 35 |
|
|
2021
Q2 | $231M | Sell |
2,228,554
-8,120
| -0.4% | -$841K | 0.87% | 42 |
|
|
2021
Q1 | $187M | Sell |
2,236,674
-168,889
| -7% | -$14.1M | 0.73% | 49 |
|
|
2020
Q4 | $219M | Buy |
2,405,563
+2,404,717
| +284,246% | +$219M | 0.91% | 42 |
|
|
2020
Q3 | $68K | Hold |
846
| – | – | ﹤0.01% | 125 |
|
|
2020
Q2 | $58K | Buy |
+846
| New | +$58K | ﹤0.01% | 100 |
|